What is Indegene?
Founded in 1998 and headquartered in Bangalore, India, Indegene operates as a specialized technology-led healthcare solutions provider. The company distinguishes itself through a unique synthesis of deep domain knowledge and fit-for-purpose technology, designed to address the evolving needs of the pharmaceutical and life sciences industries. By utilizing an agile and scalable operating model, Indegene assists global organizations in optimizing their commercialization processes, medical affairs, and clinical development workflows. Its market position is defined by a commitment to delivering measurable outcomes through data-driven insights and advanced digital platforms, making it an essential partner for enterprises seeking to modernize their healthcare delivery systems.
How much funding has Indegene raised?
Indegene has raised a total of $200M across 1 funding round:
Stock Offering
$200M
Stock Issuance/Offering (2021): $200M with participation from The Carlyle Group and Brighton Park Capital
Key Investors in Indegene
The Carlyle Group
The Carlyle Group is a global investment firm specializing in private equity with operations across North America, Europe, Asia, Australia, the Middle East, Africa, and Latin America. The company manages numerous funds focused on four primary investment disciplines: buyouts, venture and growth capital, real estate, and leveraged finance.
Brighton Park Capital
Brighton Park Capital is a growth equity firm that invests in software, healthcare, and tech-enabled services businesses, providing strategic support to help companies scale their operations.
What's next for Indegene?
Looking ahead, Indegene is poised to leverage its recent capital infusion to deepen its technological capabilities and expand its global service delivery infrastructure. The strategic focus will likely center on enhancing its proprietary AI-driven platforms, which are critical for streamlining complex healthcare workflows and improving patient engagement outcomes. As the industry shifts toward more personalized and data-centric models, Indegene's ability to integrate its deep industry expertise with scalable technology will be a primary driver of its long-term growth. The company is expected to prioritize inorganic growth opportunities and talent acquisition to maintain its competitive edge in the rapidly evolving healthcare technology landscape, ensuring sustained value creation for its stakeholders and clients alike.
See full Indegene company page
